Pre-order Enquiry
Request Free Sample
Global Transdermal Drug Patches Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
SKU ID : Maia-16199154 | Publishing Date : 20-Aug-2020 | No. of pages : 104
Request Sample
Request Customization
Check Discounts
A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body.
Based on the Transdermal Drug Patches market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Transdermal Drug Patches market covered in Chapter 5:
Hisamitsu Pharmaceutical Co., Inc.
Novartis International AG
Mylan N.V.
UCB
Boehringer Ingelheim
Johnson & Johnson
LTS Lohmann Therapie-Systeme AG
Nitto Denko Corporation
NAL Pharmaceutical Group Limited
GlaxoSmithKline
Endo International
Teikoku Seiyaku
In Chapter 6, on the basis of types, the Transdermal Drug Patches market from 2015 to 2025 is primarily split into:
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others
In Chapter 7, on the basis of applications, the Transdermal Drug Patches market from 2015 to 2025 covers:
Hypertension
Contraception
Analgesia
Smoking Cessation
Angina
Hormone Replacement
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
2019
Based on the Transdermal Drug Patches market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Transdermal Drug Patches market covered in Chapter 5:
Hisamitsu Pharmaceutical Co., Inc.
Novartis International AG
Mylan N.V.
UCB
Boehringer Ingelheim
Johnson & Johnson
LTS Lohmann Therapie-Systeme AG
Nitto Denko Corporation
NAL Pharmaceutical Group Limited
GlaxoSmithKline
Endo International
Teikoku Seiyaku
In Chapter 6, on the basis of types, the Transdermal Drug Patches market from 2015 to 2025 is primarily split into:
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others
In Chapter 7, on the basis of applications, the Transdermal Drug Patches market from 2015 to 2025 covers:
Hypertension
Contraception
Analgesia
Smoking Cessation
Angina
Hormone Replacement
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years:
2015-2019Base Year:
2019Estimated Year:
2020Forecast Period:
2020-2025Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
